Principal Financial Group Inc Ampio Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.16 - $0.47 $5,883 - $17,281	-36,770 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.42 - $0.62 $1,013 - $1,496	2,413 Added 7.02%	36,770 $17,000
Q4 2021 Feb 09, 2022	SELL	$0.56 - $1.71 $3,961 - $12,096	-7,074 Reduced 17.07%	34,357 $20,000
Q3 2021 Nov 09, 2021	BUY	$1.21 - $1.8 $13,334 - $19,836	11,020 Added 36.24%	41,431 $69,000
Q2 2021 Aug 10, 2021	BUY	$1.56 - $1.98 $47,441 - $60,213	30,411 New	30,411 $50,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.